| Long name: |
GIT2 Primary Polyclonal Antibody |
| Also known as: |
GIT2 PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
GIT2 |
| Specificity: |
This is a highly specific antibody against GIT2 |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human GIT2 |
| Gene ID number: |
9815 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
G protein-coupled receptor kinases (GRKs) are activated by activated G protein-coupled receptors, GIT1 (for GRK-interactor 1) and GIT2 are GTPase-activating proteins (GAP) for members of the ADP ribosylation factor (ARF) family of small GTP-binding proteins, GIT1 overexpression results in reduced internalization and resensitization of b2-adrenergic receptor, and they function to phosphorylate and inactivate cell surface receptors in the heterotrimeric G protein signaling cascade (3, thus reducing b2-adrenergic receptor signaling (5), which are involved in vesicular trafficking (5, 2), 4), 6), Heterotrimeric G protein-mediated signal transduction is a dynamically regulated process with the intensity of signal decreasing over time despite the continued presence of the agonist (1 |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
ARF GTPase activating protein GIT2, ARF GTPase-activating protein GIT2, ARF GTPase-activating protein GIT2, CAT 2, CAT-2, CAT2, Cool associated tyrosine phosphorylated protein 2, Cool interacting tyrosine phosphorylated protein 2, Cool-interacting tyrosine-phosphorylated protein 2, Cool-interacting tyrosine-phosphorylated protein 2, DKFZp686G01261, G protein coupled receptor kinase interacting ArfGAP 2, G protein coupled receptor kinase interactor 2, G protein-coupled receptor kinase-interactor 2, G protein-coupled receptor kinase-interactor 2, GIT 2, GIT2, GIT2_HUMAN, GRK interacting protein 2, GRK-interacting protein 2, KIAA0148, MGC760, ARF GAP GIT2 |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
GIT2 |
| Short name: |
GIT2 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
GIT2 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
4273 |
| Gene: |
GIT2 |
More about : GIT2 |
| Long gene name: |
GIT ArfGAP 2 |
| Synonyms gene name: |
G protein-coupled receptor kinase interactor 2 G protein-coupled receptor kinase interacting ArfGAP 2 |
| Synonyms: |
KIAA0148 PKL |
| Synonyms name: |
Paxillin kinase linker |
| Locus: |
12q24, 11 |
| Discovery year: |
2000-07-31 |
| GenBank acession: |
AF124491 |
| Entrez gene record: |
9815 |
| Pubmed identfication: |
9826657 10896954 |
| RefSeq identity: |
NM_057169 |
| Classification: |
Ankyrin repeat domain containing ArfGAPs |
| Havana BLAST/BLAT: |
OTTHUMG00000169313 |